MIF anticorps (C-Term)
Aperçu rapide pour MIF anticorps (C-Term) (ABIN185406)
Antigène
Voir toutes MIF AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Classe de qualité
-
-
Épitope
- C-Term
-
Fonction
- MIF
-
Séquence
- NAANVGWNNS TFA
-
Réactivité croisée
- Humain, Souris, Rat
-
Purification
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
-
Immunogène
- Peptide with sequence C-NAANVGWNNSTFA, from the C Terminus of the protein sequence according to NP_002406.1.
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
Immunohistochemistry: Paraffin embedded Human Thymus. Recommended concentration: 5 μg/mL.
Western Blot: Approx 13 kDa band observed in Human Lymph Node, and Thymus lysates and similar bands are observed in lysates of cell lines Daudi and Jurkat (calculated MW of 12.5 kDa according to NP_002406.1). Recommended concentration: 0.01-0.03 μg/mL. Pri
Peptide ELISA: antibody detection limit dilution 1:128000.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5 mg/mL
-
Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Minimize freezing and thawing.
-
Stock
- -20 °C
-
Stockage commentaire
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
-
- MIF (Macrophage Migration Inhibitory Factor (Glycosylation-Inhibiting Factor) (MIF))
-
Autre désignation
- MIF
-
Sujet
- MIF, macrophage migration inhibitory factor (glycosylation-inhibiting factor) , HGNC:7097, GIF, GLIF, MMIF, glycosylation-inhibiting factor, phenylpyruvate tautomerase, macrophage migration inhibitory factor
-
ID gène
- 4282
-
NCBI Accession
- NP_002406
-
Pathways
- Regulation of Systemic Arterial Blood Pressure by Hormones, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Regulation of Carbohydrate Metabolic Process, Feeding Behaviour, Smooth Muscle Cell Migration, Negative Regulation of intrinsic apoptotic Signaling
Antigène
-